Stay updated on CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Sign up to get notified when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.

Latest updates to the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page
- CheckyesterdayChange DetectedThe record describes a Phase 1 study of CLR 131 for children, adolescents, and young adults with relapsed or refractory cancers, including its eligibility criteria, treatment plan, and outcome measures. It also provides the study’s recruitment status and participating locations.SummaryDifference64%

- Check8 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check15 days agoChange DetectedA sitewide NIH banner announces a website transition and says NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check22 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header and a Home link, indicating that access to the study record is blocked.SummaryDifference20%

Stay in the know with updates to CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.